Superbugs & Superdrugs – Pushing financial incentives and collaborative incentives to accelerate clinical success

March 16-17, 2016
London, United Kingdom

The Superbugs and Superdrugs conference addressed the core challenges in the industry from: Investment, R&D to hospital hygiene, consumer engagement and reviewed current strategies.

Jean-Pierre Paccaud, Business Development Director from DNDi, discussed global product development partnerships as a means of fostering new antibiotic treatments and their responsible use.



Date: Wednesday, March 16, 2016

A Global Health R&D Approach to Innovation, Conservation, and Access to New Antibiotic Treatments
Jean-Pierre Paccaud, Business Development Director, DNDi


More information: SMI Events website